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Abstract 
 
Object:  
Infection of deep brain stimulation (DBS) hardware has a significant impact on 
patient morbidity. Previous experience suggests that infection rates appear to be 
higher after implantable pulse generator (IPG) replacement surgery than after the de 
novo DBS procedure. Here we examine the effect of a change in practice during DBS 
IPG replacements in our institution. 
 
Methods:  
Starting January 2012, patient screening for meticillin resistant Staphylococcus aureus 
(MRSA) and where necessary, eradication was performed prior to elective DBS IPG 
change. Moreover, topical vancomycin was placed in the IPG pocket during surgery. 
We then prospectively examined the infection rate in patients undergoing DBS IPG 
replacement in our center over a 3-year period with at least 9-months follow up. 
 
Results:  
The total incidence of infection in our prospective consecutive series of 101 IPG 
replacement procedures was 0% with mean follow up of 24 months (SD 11). This was 
significantly lower than our previously published historical control group, prior to 
implementing the change in practice, where the infection rate for IPG replacement 
was 8.5% (8/94 procedures) (p = 0.0025). 
 
Conclusion:  
This study suggests that a change in clinical practice can significantly lower infection 
rates in patients undergoing DBS IPG replacement. These simple measures can 
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minimise unnecessary surgery, loss of benefit from chronic stimulation and costly 
hardware replacement, improving further the cost efficacy of DBS therapies. 
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Introduction 
 
Deep Brain Stimulation (DBS) was popularised by the Grenoble group22 and 
surpassed stereotactic ablation as the predominant treatment in functional 
neurosurgery at the end of the last millennium. DBS is now an established treatment 
for a number of movement disorders including Parkinson’s disease, dystonia and 
tremor. This has raised interest in the possible use of DBS for severe and unremitting 
psychiatric disorders including obsessive compulsive disorder and depression3129.  
 
Despite the surge in popularity of DBS only a small number of publications have 
specifically analysed the complications of DBS surgery3,4,6,15,32,40,413,4,6,14,30,38,39, 
and even fewer have assessed interventions that can reduce the rate of adverse 
events3,14,24,26,28,37,463,13,22,24,26,35,44. 
  
Reported infection rates vary between centres from 0 – 22%7,427,40. Our group 
recently published data demonstrating that infection rates after IPG replacement are 
significantly higher when compared to other types of DBS related surgery3230. Other 
authors have reported similar trends33. However, the overall picture is far from clear, 
as other groups reported infection rate similar to de novo surgery4,364,34.  
 
Miller and colleagues previously reported a significant improvement in hardware 
related infection in all stereotactic and functional neurosurgical procedures with the 
use of topical antibiotics2826. Moreover, it is well documented that colonisation with 
Staphylococcus aureus (SA) is an independent risk factor for the development of post-
surgical infection4442, and this risk may be as high as 33%2927. 
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Therefore, since January 2012 we adapted our surgical procedure with the aim of 
reducing the rate of infection after IPG replacement surgery. Together with our local 
infection control team we introduced the use of MRSA screening and eradication as 
well as intraoperative topical vancomycin wash during IPG replacement. 
 
The aim of this prospective study is to assess whether this change in practice made a 
significant impact upon infection rates after IPG replacement surgery when compared 
to historical controls. 
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Materials and Methods 
 
Surgical reports and clinical notes were reviewed in all 171 patients (89 male, 82 
female) who underwent IPG replacement surgery at the National Hospital of 
Neurology and Neurosurgery, Queen Square, London, from November 2002 until 
December 2014.  Prior to January 2012 all data collected was retrospective. From 
January 2012 until December 2014 all patients undergoing IPG change surgery were 
prospectively followed up.  
 
Baseline patient characteristics (age at surgery, gender, diagnosis, brain target) as well 
as details of the operation performed were collected for each patient. Before January 
First1, 2012 the IPG pocket was vigorously washed with copious saline. After this 
date all patients underwent MRSA screening and eradication, where appropriate, prior 
to surgery and, at surgery the IPG pocket was instilled with a vancomycin wash prior 
to closure (further details below).   
 
Patients were grouped into an historical “control” group and a “prospective” group 
following this change in practice. All patients had a minimum follow up time of nine 
months.  
 
Information on any DBS related infection, including type, site and microbiological 
diagnosis was collected for all patients with infection. The definition of recorded 
infection is the same as in our previous study3230. Only infections in direct relation to 
the hardware were considered. Infections were defined if any of the following were 
present: a) clinical suspicion of an infection (i.e. redness, swelling, warmth or fluid 
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surrounding any of the DBS components beyond that expected due to post-surgical 
inflammation, with either elevated temperature / inflammatory markers; b) purulent 
exudates from the suspected site of infection; c) microbiological evidence; d) skin 
erosion with any of the above. 
 
The infection rate was calculated as the number of infections per patient as well as the 
number of infections per procedure.  
 
Microbial Screening and Eradication Protocol 
All “prospective” patients attended pre-operative assessment clinic where they 
underwent skin and nasal screening for MRSA colonisation. All patients who had 
negative colonisation results continued to surgery without eradication. Patients 
underwent MRSA eradication if they had either: (a) positive MRSA colonisation 
result, (b) unable to attend pre-operative assessment clinic, (c) historically MRSA 
colonisation positive or (d) delayed elective surgery in known MRSA carrier with or 
without previous eradication. All patients with delayed elective surgery underwent 
repeat MRSA screening. Figure 1.  
 
See Table 1 for details of eradication protocol.  
 
Surgical Procedure 
Replacement of IPG 
Patients received 1.5g IV cefuroxime single dose or 500mg IV clarithromycin single 
dose in cases of penicillin allergy at induction. If they were MRSA positive 
Teicoplanin 6mg/kg IV was added to the primary prophylaxis. With the patient under 
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general or local anaesthesia, the pocket of the IPG was opened via the old scar. If the 
scar was “unsightly” the scar was excised together with an ellipse of skin.  The old 
IPG was replaced with the new IPG placed in the fibrous pocket. When exchanging 
the old IPG for more bulky hardware (e.g.: Kinetra IPG being replaced with adaptor 
plus Activa PC , Medtronic, Minneapolis, MN), the new hardware was sometimes 
placed in a deeper pocket, formed beneath the pectoralis major muscle via a muscle 
splitting approach, especially when the overlying skin was deemed thin.  
 
Before January first 2012 the pocket was washed with copious amounts of saline. 
After this date, vancomycin / saline wash was used (20ml of 1mg/ml vancomycin 
solution). The wound was closed in layers with carefully buried absorbable sutures 
and interrupted nylon for skin closure. The patient received three further doses of 
cefuroxime 750mg IV at eight hourly intervals or the appropriate alternative if 
penicillin allergic or MRSA positive. Dressings were not removed unless they were 
heavily blood stained and sutures were removed after 10-14 days. Patients were 
instructed to keep the wound dry until 24 hours after suture removal. 
 
Statistical Analysis 
A non-paired student t-test was used to compare the ages of patients with and without 
infection, between groups and the number of surgeons per operation. The infection 
rate between groups was compared with a Fisher exact test using a 2x2 contingency 
table. A p-value <0.05 was considered significant. 
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Results 
 
Baseline Characteristics 
In total, 171 patients underwent a total of 195 IPG replacement procedures. Of those 
in the historical control group, 80 patients underwent 94 IPG replacement surgeries 
(Age: 48±20, 48% male). This included 15 procedures (18.8%) in which patients had 
one or more previous IPG replacement surgeries. In the “prospective” group, 91 
patients underwent 101 IPG replacement surgeries (Age 54±15, 56% male) and 
included 24 procedures (23.7%) in which patients had one or more previous IPG 
replacement surgeries. There was no significant difference in gender, primary 
indication for DBS surgery, brain target, or rates of diabetes between the two groups 
(Table 2).  
 
Minimum follow up time was 9 months in both groups with mean follow up time 
24±11 months in the “prospective” group and 73±26 months in the control group 
(p=0.0001). The number of surgeons involved was higher in the control than in the 
prospective group 1.8 versus 1.4 (p=0.0002). Patients in the prospective group were 
older and had undergone more previous IPG changes (Table 2). 
 
Rate of MRSA colonisation in prospective cohort 
There were no confirmed MRSA colonisations within the prospective group. 
However, four patients underwent MRSA eradication, three of whom had historical 
MRSA colonisation and one who failed to attend for MRSA screening.  
 
Postoperative Infections  
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In total 8 postoperative infections occurred in 6 patients in the historical control 
group. This corresponds to a patient infection rate of 7.5% and a procedure infection 
rate of 8.5%.  There were no infections in the “prospective” group. This difference is 
statistically significant (See Figure 2). Information on patients with infection is 
detailed in brief in Table 3 and in more detail in our previous publication3230. The 
mean ± SD duration until infection in the control group was 3.1±5.8 months. None of 
the infections were secondary to MRSA. 
 
Reason for IPG Change 
The most common reason for IPG change was depletion / near depletion of the IPG´s 
battery in both groups. Replacement of IPG after prior hardware removal because of 
infection was the indication in 12% of the historical control group versus 0% in the 
prospective group (p=0.0002). (Table 4).  
 
Adverse Events 
There were no adverse events noted in relation to the use of topical vancomycin wash 
or microbial screening/eradication.   
 
Patients with previous DBS related infections 
The historical control group contained one patient (1/80, 1.2%) with a previous DBS 
related infection and the prospective cohort contained 4 patients (4/91, 4.4%) who had 
previous infection of DBS hardware. This difference is not statistically significant. 
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Special Cases 
Of the 6 patients with IPG infections in the historical group, two deserve further 
discussion. Patient 2 underwent surgery for tardive dystonia and suffered three 
infections after IPG replacement surgery and four in total. The initial infection 
affected the IPG alone and was managed by cutting of the cables below the cranial 
connector site and extraction of the cut cables and IPG. The subsequent infection 
occurred two months later and was associated with erosion of the distal end of the cut 
extension cable through the skin and the cable stump was removed. Four weeks later a 
purulent spot over the left peri-coronal wound was noted and the patient was admitted 
to hospital for removal of the leads. These were all considered separate infections as 
they occurred at different time points all related to the most recent surgery (IPG 
replacement). Three and a half months later the entire system was re-implanted but 
the patient developed a subcutaneous infection around the IPG pocket that resulted in 
removal of the infected components, leaving the leads in place. Finally new cables 
and IPG were re-inserted 4 months later. This patient suffered from type II diabetes 
mellitus.  
 
Patient 3 with severe dystonia and cachexia underwent IPG replacement due to near 
depletion of the battery and was discharged back to his nursing home. The patient 
presented to hospital seventeen months later with erosion of the IPG through the skin. 
On presentation no clinical signs of infection were present and an attempt was made 
to rescue the IPG by excising the wound margins and forming a new pocket. This was 
followed by development of a purulent infection.  
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Discussion 
 
The use of an intra-operative vancomycin wash and microbial screening significantly 
reduced the rate of infection after IPG replacement surgery from a procedure infection 
rate of 8.5% and patient infection rate of 7.5% to 0%. 
 
In 5/6 patients with infection in the historical control group, the causative organism of 
purulent infection was Staphylococcus species. The rate of skin colonisation of 
Staphylococcus aureus is over 70% in patients with confirmed skin and soft tissue 
infections10,2510,23. Indeed, the most common causative organism responsible for 
hardware infection in DBS surgery is staphylococcal species3,4,323,4,30. Importantly, 
despite proper skin disinfectant and draping during surgery, bacteria including 
coagulase negative staphylococci and Propionibacterium acnes will begin to colonise 
the skin within one hour with a marked bacterial colonisation load at two hours1212. 
 
Staphylococcus aureus (SA) is a common commensal species that affects up to 2/3 of 
healthy individuals throughout their lifetime22,2520,23. The skin provides a remarkably 
resistant barrier to infection by colonised bacteria and this is due to a large extent to 
the production of antimicrobial proteins such as defensins and cathelicidins3028. Skin 
breaches during surgery allow the spread of SA within the skin and deeper tissue 
layers. MRSA infections can be more serious than MSSA infections due to their 
reduced sensitivity to commonly used antibiotics and result in worse clinical 
outcomes4543.  
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Within the National Health Service in England Public Health England report that the 
rate of MRSA bacteraemia1615 and surgical site infections9 (9 have fallen markedly 
over the last decade. The reason for this is unclear but screening and subsequent 
isolation and eradication protocols are believed to be contributory4341. 
  
Topical application of antibiotics produces far higher intra-wound concentrations than 
would be possible via intravenous administration alone. This is especially true in 
patients undergoing IPG replacement surgery where the subcutaneous fibrous pocket 
has a reduced blood supply. Indeed, the topical use of a variety of antibiotics has long 
been used effectively in treatment and prophylaxis of wound infection5,33,355,31,33. 
Moreover, in neurosurgical shunt operations the use of local antibiotic injected 
directly into the shunt reduced the infection rate from 6% to 0.4% in a controlled trial 
of 802 shunt procedures3432.  
 
Staphylococcus species are highly sensitive to vancomycin. Thus the use of a local 
vancomycin wash in hardware implantation surgery into subcutaneous tissue is 
judicious. In this study the use of a vancomycin wash in over 100 procedures with 
average follow up of 2 years has resulted in no infections. Importantly there were no 
adverse events noted from the use of vancomycin wash.  
 
Change in Antibiotic Regimen 
Bhatia and colleagues33 changed the peri-operative antibiotic regimen from 
intravenous cefuroxime to intravenous vancomycin and gentamicin. This change 
reduced the overall infection rate and importantly reduced their rate of infection after 
IPG replacement surgery from 17.6% to 3.6%. Whilst highlighting an important trend, 
Formatted: Check spelling and grammar
Formatted: Check spelling and grammar
Formatted: Check spelling and grammar
Formatted: Check spelling and grammar
Formatted: Check spelling and grammar
Formatted: Check spelling and grammar
14 
 
this study was under-powered and the outcome was not statistically significant. The 
causative organism in this original report was Staphylococcus species in 2/3 cases of 
IPG replacement. In the highly detailed review conducted by the authors, the 
causative organism of infection was Staphylococcus species in >50% cases.  
 
Miller et al in Oregon, USA2826 meticulously collected information on all stereotactic 
and functional hardware procedures over a 5-year period. In total 614 patients 
underwent a variety of procedures including DBS, spinal cord stimulator, peripheral 
nerve stimulator and others. All patients were given peri-operative cephalosporin or 
vancomycin. In the final 18 months of this study all subcutaneous pockets were 
irrigated with neomycin/polymyxin as opposed to saline prior to skin closure. The 
overall rate of infection reduced from 5.7% to 1.2% (p<0.05) in the group with the 
antibiotic washout. The causative organism of infection was Staphylococcus species 
in 82% (23/28) of cases. 
 
In other fields of surgery and neurosurgery involving implantable hardware the use of 
topical vancomycin has led to marked reductions in the rate of postoperative 
infections. The use of a topical vancomycin powder in instrumented spinal surgery in 
a prospectively followed cohort led to a reduction in postoperative infection rates 
from 12.5% to 0%2321, a finding similar to our own.  
 
Microbial Screening and Eradication 
Colonization with Staphylococcus aureus is an independent risk factor for the 
development post-operative surgical site infections21, 44.  
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In our study, information on MRSA carrier status was not available for all historical 
controls since routine screening was not conducted until January 2012. Moreover, 
MRSA was not cultured from any of our infected patients. Nevertheless, prior 
knowledge of MRSA status led to prophylactic decontamination in 3 patients within 
our prospective cohort. Although we suspect that the majority of the benefit seen in 
terms of reduced infection rates was due to the use of topical vancomycin, we cannot 
discount a contribution from the introduction of routine MRSA screening. 
In our study information on MRSA carrier status is not available for all historical 
controls as screening was not routinely conducted until January 2012. However, it is 
well documented that colonisation with Staphylococcus aureus is an independent risk 
factor for the development post-operative surgical site infections(19,42) with 
conversion rates reported as high as 33%(27).  
 
A recent large, single centre, prospective study examined MRSA colonisation and 
infection rates on 3,785 patients awaiting cardiac surgery. Twenty-two out of 1,250 
patients were known MRSA carriers pre-operatively and eradication was successful in 
21 cases. None of these patients developed a post-operative surgical site infection. 
The remaining patients were screened preoperatively but eradication in 103 MRSA 
positive patients was either not started or not completed by the time of surgery. 
Eleven percent of these patients subsequently developed an MRSA infection. This 
was significantly higher than patients who had confirmed MRSA negative status pre-
operatively (11 vs. 0.5%, p<0.001)(19). This study emphasises the importance of 
meticulous screening and eradication of MRSA colonisation in reducing surgical site 
infections. 
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Diabetes Mellitus 
 
It is noted in neurosurgery1111 and other fields of surgery2927 that diabetes is an 
independent risk factor for the development of post operative surgical infections. 
Importantly, in relation to this study, patients with MRSA colonisation who 
underwent cardiac surgery were more likely to develop post operative infection if they 
had a confirmed pre-operative diagnosis of diabetes2119.  
 
In our patient groups the rate of diagnosed diabetes mellitus was low and similar 
between the two groups. This rate is similar to other published series of DBS 
patients36,4134,39. Due to the low number of diagnoses we cannot comment on its 
significance as a contributory factor in the development of post-operative infections. 
However, a number of other DBS related publications have noted that diabetes does 
not appear to be correlated to the development of post operative 
infections20,39,4118,37,39.  
 
Timing of Infection / Follow up 
In this study 6/8 (75%) IPG infections in the control group occurred within 2 months 
of surgery, 7/8 (88%) occurred within 6 months and all infections occurred within 17 
months of surgery. The mean follow up of 24 months and minimum follow up of 9 
months in the “prospective” group may thus be considered adequate to determine the 
rate of post-procedural infections. Therefore, it is unlikely that the (inevitably) shorter 
duration of follow up in the second group contributed to the lower rate of infection in 
any meaningful way. Indeed, other studies support the notion that the majority of 
post-surgical infections (roughly 80%) occur within the first few months of surgery 
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with a smaller proportion, often not directly related to surgery, occurring at a later 
stage, usually up to two years post-procedure3,4,323,4,30.  
 
Number of surgeons 
The number of surgeons was higher in the control group on average by 0.4 surgeons 
over 101 procedures. This might have contributed to the higher infection rate within 
the control group, although this is uncertain. Other groups have noted that the number 
of individuals present in the operating room is related to a higher infection rate 3937. 
However, at our institution the consultant (attending) surgeon listed in the operative 
record and supervising the procedure does not always scrub for the procedure. 
Therefore, these numbers must be interpreted with caution and it is not clear whether 
the number of scrubbed surgeons is a significant contributing factor.  
 
Number of previous IPG replacement surgeries 
We postulated in our previous publication that the number of IPG replacement 
surgeries might be an independent risk factor for infection3230. Our reasoning was 
two-fold: that the fibrous pocket around the IPG does not provide an adequate 
inflammatory response to infection and the likely reduced penetrance of prophylactic 
intravenous antibiotics increases the likelihood of an infection. Indeed, the number of 
pacemaker changes is a risk factor for infection when compared to de novo 
implantation in cardiac surgery1,8,17,181,8,16,17. Furthermore, in hip replacement 
surgery the rate of infection is 18% higher after repeat revision when compared to de 
novo surgery2725. A recent publication has confirmed an increasing infection rate in 
multiple DBS IPG changes3836.  
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In our prospective group, 15% of all surgeries occurred in patients who had two or 
more previous IPG replacements and almost a quarter of all patients had at least one 
previous IPG change. This is to be compared to 4% (p=0.048) and 16% (p=NS) of 
patients in our control group respectively. Although the number of IPG changes is an 
independent risk factor for infection, our protocol appears to significantly negate this 
risk in IPG replacement surgery.  
 
Study Limitations 
Comparison of a prospective cohort with a historical control group may give rise to 
potential confounds that contributed to the difference in infection rates. Nevertheless, 
our DBS service has always been alert to the importance of minimizing infection. No 
changes were made to the surgical procedure in the prospective group other than the 
addition of topical vancomycin wash. Surgical learning curves may also lead to higher 
early complication rates13. However, a surgical learning curve may not be present 
when a relatively simple procedure is performed by an experienced surgeon19. Indeed, 
the majority of infections in the historical control group did not occur in the early 
years of our DBS service32.  
 
Moreover, the prospective group was older with more repeat IPG changes, both 
independent risk factors for infection. This suggests that a greater baseline risk for the 
prospective group was reversed by using topical vancomycin wash 
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Conclusions 
The use of topical vancomycin has significantly reduced the rate of infection after IPG 
replacement surgery. MRSA screening and eradication may also have contributed to 
the reduced infection rate. No adverse events were noted and our protocol appears to 
have negated the increased risk of infection associated with multiple IPG changes. 
These simple measures prevented unnecessary surgery, loss of benefit from chronic 
stimulation and costly hardware replacement, improving further the cost efficacy of 
DBS therapies. 
In summary, MRSA screening and eradication, and the use of topical vancomycin 
have significantly reduced the rate of infection after IPG replacement surgery. 
Importantly, no adverse events were noted, and meticulous adherence to our protocol 
appears to have negated the increased risk of infection associated with multiple IPG 
changes in our prospective group. These simple measures prevented unnecessary 
surgery, loss of benefit from chronic stimulation and costly hardware replacement, 
improving further the cost efficacy of DBS therapies. 
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